Healthequity, inc. (HQY)
CashFlow / Quarterly
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Oct'14Jul'14Apr'14
Cash flows from operating activities:
Net income

-190

-21,334

19,366

41,822

13,119

15,686

22,517

22,577

5,905

10,482

16,946

14,029

4,062

6,008

8,233

8,073

3,128

4,087

4,421

4,977

1,371

3,049

3,028

2,718

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

26,561

19,069

4,949

4,773

4,687

4,582

4,396

4,520

4,810

4,006

3,654

3,482

3,643

3,418

3,178

2,947

2,871

2,065

1,915

1,750

1,703

1,544

1,392

1,251

Deferred taxes

2,975

-7,178

326

7,542

14

-1,957

362

1,989

-787

394

1,481

3,218

-1,011

-1,142

-772

34

-673

-372

-1,131

-2

-433

179

895

952

Stock-based compensation

8,650

17,576

7,590

6,028

5,596

5,734

5,488

4,239

3,842

3,665

3,793

3,010

1,999

2,068

2,509

1,822

1,629

1,483

1,677

1,094

1,732

325

403

65

(Gains) losses on marketable equity securities and other

-2,152

-1,877

3,696

23,484

-278

-809

54

-140

-500

-70

14

-41

43

17

18

18

23

0

0

0

-

-

-

-

Loss on revaluation of redeemable convertible preferred stock derivative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

735

Changes in operating assets and liabilities:
Accounts receivable

2,192

1,128

335

1,354

1,443

-441

1,884

1,420

252

609

1,886

1,987

2,972

-2,617

975

1,398

4,306

-933

376

1,425

3,031

-233

237

345

Inventories

-

-

-

-

-

-

-

-

-

-170

-190

-63

-

245

101

-22

-195

225

-77

42

-131

387

-27

5

Other assets

7,640

-99

3,342

1,694

1,325

-2,353

1,450

5,471

-2,267

-1,046

2,866

1,207

-2,612

-1,290

506

4,739

-1,314

-2,190

2,740

871

-516

-272

2,216

180

Operating lease right-of-use assets

-2,878

-2,054

-651

-635

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-4,363

1,607

494

-1,577

1,950

-250

-924

87

-156

1,070

50

-1,545

1,540

96

172

-1,241

596

692

63

-340

386

363

-285

-1,620

Accrued compensation

12,562

-2,086

2,554

-8,480

7,049

209

2,083

-4,909

6,046

-17

2,195

-4,397

4,063

306

1,750

-5,173

3,878

586

1,271

-3,260

2,292

3

1,240

-2,368

Accrued liabilities and other current liabilities

-7,896

8,713

3,173

1,769

2,580

395

-825

881

-2,102

1,686

275

625

63

839

-337

1,164

-951

-9

676

-99

-262

-368

400

-572

Operating lease liabilities, non-current

-2,524

-1,649

-583

-627

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

803

Other long-term liabilities

-33

-381

348

-17

132

143

227

71

169

159

367

244

161

219

257

583

41

50

-332

-11

7

46

13

29

Net cash provided by operating activities

30,940

17,239

31,495

25,336

32,637

28,145

29,936

22,704

19,819

22,122

24,185

15,576

14,562

15,491

13,426

2,112

7,769

11,480

5,521

1,771

4,467

5,259

3,857

1,463

Cash flows from investing activities:
Purchases of marketable securities

0

0

0

53,845

154

206

188

180

140

119

115

109

104

98

91

86

78

76

75

40,062

0

0

0

0

Purchases of property and equipment

2,106

1,688

2,366

1,126

402

777

1,569

1,121

2,076

1,221

724

1,437

940

1,455

929

321

494

625

431

826

235

430

567

480

Purchases of software and capitalized software development costs

8,422

7,714

4,021

5,497

2,626

2,651

2,604

2,097

2,726

2,488

2,438

2,728

2,231

2,839

1,957

2,003

2,139

1,775

1,531

1,451

1,569

1,335

1,804

1,712

Acquisition of intangible member assets

64

7,334

474

1,262

0

181

1,014

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-25,101

-1,646,802

-6,861

-61,730

38,240

-3,815

-5,375

-3,398

-6,958

-12,724

-12,792

-4,274

-3,275

-4,392

-2,977

-2,410

-9,379

-36,797

-2,037

-42,339

-1,804

-2,070

-2,371

-2,192

Cash flows from financing activities:
Proceeds from exercise of common stock options

4,005

778

2,335

4,229

1,591

2,869

8,302

10,167

2,244

5,248

3,243

3,829

2,596

3,418

983

145

164

598

660

493

33

14

2,132

251

Proceeds from exercise of common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

37

1,946

397

Tax benefit from exercise of common stock options

-

-

-

-

-

-

-

-

-

-

-

-

725

1,660

4,971

9,278

242

1,030

6,354

3,931

6,403

-88

-2,732

-154

Net cash provided by financing activities

11,330

988,960

461,216

4,229

1,591

2,869

8,302

10,167

2,244

5,248

3,243

3,829

3,321

5,078

5,954

9,423

242

1,475

30,506

4,424

488

83,779

5,410

802

Increase (decrease) in cash and cash equivalents

17,169

-640,603

485,850

-32,165

72,468

27,199

32,863

29,473

15,105

14,646

14,636

15,131

14,608

16,177

16,403

9,125

-1,368

-23,842

33,990

-36,144

3,151

86,968

6,896

73

Supplemental cash flow data:
Interest expense paid in cash

21,557

148

51

50

41

61

51

50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes paid in cash, net of refunds received

150

8

9,170

-51

-41

74

515

39

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable or accrued liabilities at period end

319

165

-18

21

31

-8

-477

491

-238

185

-80

133

-544

190

371

8

-176

221

0

0

-

-

-

-

Exercise of common stock options receivable

-

-66

-54

141

-

-107

-662

797

-

-1,017

1,017

0

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of common stock warrants to common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

21

2,238

75

Series D-3 redeemable convertible preferred stock dividend

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,677

175

169

Software
Purchases of intangible assets

1,426

-171

329

158

44

-19

58

117

-

-

-

141

-

-

-

111

-

215

0

0

-

-

-

-